109 results
8-K
EX-99.1
RYTM
Rhythm Pharmaceuticals Inc.
7 May 24
Rhythm Pharmaceuticals Rhythm Pharmaceuticals Reports First Quarter 2024 Financial Results and Business Update
7:10am
associated with the acquisition of LG Chem’s proprietary compound LB54640. Additional increased costs were associated with salaries, benefits and stock-based … . The year-over-year increase was primarily due to increased compensation and benefits related costs associated with additional headcount to support our
8-K
EX-3.1
RYTM
Rhythm Pharmaceuticals Inc.
16 Apr 24
Entry into a Material Definitive Agreement
7:00am
to all of the benefits of this Certificate of Designations equally and ratably with all other Convertible Preferred Stock then outstanding.
(k
8-K
EX-99.1
ltg0a rhrb0e9p
1 Apr 24
Rhythm Pharmaceuticals Secures $150 Million in Convertible Preferred Stock Financing
5:25pm
8-K
EX-10.1
xlystzfi71d ry9h
1 Apr 24
Rhythm Pharmaceuticals Secures $150 Million in Convertible Preferred Stock Financing
5:25pm
8-K
wal5w3 knan8kzb8i
1 Apr 24
Rhythm Pharmaceuticals Secures $150 Million in Convertible Preferred Stock Financing
5:25pm
424B5
lyavo890pfnts
29 Feb 24
Prospectus supplement for primary offering
4:44pm
8-K
EX-99.1
2o1rt8r93h2qdjeu mfo
22 Feb 24
Rhythm Pharmaceuticals Reports Fourth Quarter 2023 Financial Results and Business Update
7:01am
8-K
cjnbipx62rml
4 Jan 24
Entry into a Material Definitive Agreement
7:00am
8-K
EX-3.1
t5nypety2157mf
18 Dec 23
Amendments to Articles of Incorporation or Bylaws
4:16pm
8-K
8l4nxy2zs169k
6 Dec 23
Other Events
4:30pm
8-K
EX-99.1
bvb23piwxterwgij
7 Nov 23
Rhythm Pharmaceuticals Reports Third Quarter 2023 Financial Results and Business Update
7:05am
8-K
zxqvfca 2wpem
21 Aug 23
Other Events
4:30pm
8-K
EX-10.3
jkgl84 kw9
3 Aug 23
Departure of Directors or Certain Officers
5:22pm
8-K
EX-10.2
hqmrmyhfuaqieyv5l5kc
3 Aug 23
Departure of Directors or Certain Officers
5:22pm